
As demand for high-purity oligonucleotides continues to grow across therapeutic and research applications, downstream purification remains a critical bottleneck. Conventional ion-exchange and solid-phase chromatographic methods can be costly, difficult to scale, and often require multiple purification steps to achieve the desired purity and yield. Developing a simpler and more scalable alternative is increasingly important for efficient oligonucleotide manufacturing.
This application note explores the use of ion-exchange centrifugal partition chromatography (IEX-CPC) as a liquid–liquid purification approach that eliminates the need for expensive solid stationary phases. By leveraging tunable solvent systems and partition-based separation, CPC enables selective isolation of oligonucleotides while maintaining high loading capacity and cost efficiency. The technique also offers potential advantages in removing challenging impurities such as endotoxins through optimized biphasic solvent systems.
Through a practical case study, the note demonstrates how a single-step CPC process can achieve high purity and yield for a model oligonucleotide, while remaining scalable and compatible with industrial purification workflows.
Single-step purification without solid stationary phases
CPC enables high-purity oligonucleotide isolation without expensive ion-exchange resins or multi-column workflows, reducing complexity while maintaining strong separation performance.
High purity and yield in a scalable process
The application demonstrates that CPC can achieve >96% purity with high recovery in a single purification step, supporting efficient scale-up from development to production.
Effective removal of challenging impurities
Tunable biphasic solvent systems allow selective separation of closely related impurities and support endotoxin reduction, addressing key challenges in oligonucleotide downstream processing.
Cost-efficient and flexible operation
Liquid–liquid CPC offers high loading capacity, adjustable solvent systems, and reduced consumable costs, making it a practical and scalable alternative for modern oligonucleotide purification workflows.


RotaChrom Technologies develops and manufactures industrial-scale centrifugal partition chromatography (CPC) technology platforms. Founded in 2014, RotaChrom distributes its CPC devices around the world. With the help of their industry-leading chemists and engineers, their instruments revolutionized purification by providing cost-effective industrial-scale chromatography solutions to customers in various industries, including pharmaceutical, biotechnology, chemistry, nutraceutical, and botanical extracts.